Results 221 to 230 of about 96,425 (243)

Biological Activities, Health Benefits and Synthesis of Equol and Its Derivatives: A Comprehensive Review

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Biological activities, health benefits and structures of equol and its derivatives. ABSTRACT Equol is a metabolite transformed from daidzein by intestinal microorganisms and has received extensive attention due to its various pharmacological activities and therapeutic potential.
Jiao‐Jiao Zhuo   +2 more
wiley   +1 more source

Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma

open access: yesGlobal Challenges, Volume 10, Issue 1, January 2026.
This article comprehensively examines the evolving landscape of systemic therapy for advanced hepatocellular carcinoma. It covers the progress in tyrosine kinase inhibitors and immune checkpoint inhibitors, analyzes the efficacy of novel combination strategies, and discusses current challenges like drug resistance and the lack of biomarkers.
Yongxin Yu   +5 more
wiley   +1 more source

Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid Gliosis. [PDF]

open access: yesAm J Surg Pathol
Tang V   +10 more
europepmc   +1 more source

Biological heterogeneity in adult IRF4‐rearranged large B‐cell lymphoma: Stratification by age and anatomical site

open access: yesHemaSphere, Volume 10, Issue 1, January 2026.
Abstract Large B‐cell lymphoma (LBCL) with IRF4 rearrangement (LBCL‐IRF4‐R) is a rare subtype predominantly diagnosed in children and young adults. Whether adult LBCL cases with IRF4 rearrangement (IRF4‐R) should be classified as LBCL‐IRF4‐R remains unclear. Clinicopathological and molecular features of 61 adult LBCL cases with IRF4‐R were analyzed and
Yuxiu Zhang   +12 more
wiley   +1 more source

Genetic differences between primary colorectal cancer and its paired synchronous and metachronous metastases

open access: yesInternational Journal of Cancer, Volume 158, Issue 1, Page 120-130, 1 January 2026.
What's new? Colorectal cancer (CRC) frequently metastasizes to the liver, either synchronously with primary diagnosis or metachronously, after variable time intervals. Although implicated, the role of genetic factors in driving synchronous and metachronous disease progression remains uncertain.
Marie Rajtmajerova   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy